Equivalent thrombotic risk with Warfarin, Dabigatran, or Enoxaparin after failure of initial direct oral anticoagulation (DOAC) therapy

Margaret Shyu, Angela Liu, Anya Srikureja, Alison Gregorian, Andrew Srisuwananukorn, Douglas Tremblay, Leonard Naymagon

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Equivalent thrombotic risk with Warfarin, Dabigatran, or Enoxaparin after failure of initial direct oral anticoagulation (DOAC) therapy'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science